12,041 Shares in Addus HomeCare Corporation $ADUS Purchased by Van Hulzen Asset Management LLC

Van Hulzen Asset Management LLC purchased a new stake in shares of Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 12,041 shares of the company's stock, valued at approximately $1,210,000. Van Hulzen Asset Management LLC owned 0.06% of Addus HomeCare as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also added to or reduced their stakes in ADUS. Cetera Trust Company N.A bought a new stake in Addus HomeCare in the second quarter worth about $283,000. Paradigm Capital Management Inc. NY bought a new position in shares of Addus HomeCare during the 2nd quarter valued at approximately $5,312,000. Connor Clark & Lunn Investment Management Ltd. bought a new position in shares of Addus HomeCare during the 2nd quarter valued at approximately $2,899,000. Globeflex Capital L P purchased a new stake in shares of Addus HomeCare during the 2nd quarter worth approximately $1,635,000. Finally, Evolve Private Wealth LLC purchased a new stake in shares of Addus HomeCare during the 2nd quarter worth approximately $585,000. Hedge funds and other institutional investors own 95.35% of the company's stock.

Wall Street Analyst Weigh In

Several research firms recently commented on ADUS. Royal Bank Of Canada upped their price objective on Addus HomeCare from $130.00 to $134.00 and gave the company an "outperform" rating in a research note on Wednesday, August 5th. Weiss Ratings raised Addus HomeCare from a "hold (c-)" rating to a "hold (c)" rating in a research report on Thursday, July 9th. Barclays boosted their target price on Addus HomeCare from $92.00 to $96.00 and gave the company an "underweight" rating in a research note on Wednesday, July 8th. Citizens Jmp reaffirmed a "market outperform" rating and set a $142.00 price target on shares of Addus HomeCare in a research report on Monday, May 18th. Finally, Citigroup reiterated a "market outperform" rating on shares of Addus HomeCare in a research note on Friday, July 24th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $130.88.

Insider Activity at Addus HomeCare

In other news, insider Heather Brianne Dixon sold 288 shares of the business's stock in a transaction dated Monday, June 22nd. The stock was sold at an average price of $93.77, for a total value of $27,005.76. Following the completion of the sale, the insider owned 44,371 shares of the company's stock, valued at approximately $4,160,668.67. The trade was a 0.64% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 4.10% of the company's stock.

Addus HomeCare Stock Up 0.0%

Shares of NASDAQ:ADUS opened at $120.82 on Tuesday. The firm has a fifty day moving average price of $109.99 and a two-hundred day moving average price of $102.58. The company has a market cap of $2.26 billion, a price-to-earnings ratio of 21.20, a PEG ratio of 1.62 and a beta of 0.87. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.69 and a quick ratio of 1.69. Addus HomeCare Corporation has a one year low of $87.95 and a one year high of $124.43.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last issued its quarterly earnings data on Monday, August 3rd. The company reported $1.73 EPS for the quarter, topping the consensus estimate of $1.70 by $0.03. The company had revenue of $377.41 million during the quarter, compared to analyst estimates of $376.24 million. Addus HomeCare had a return on equity of 9.96% and a net margin of 7.13%.Addus HomeCare's revenue was up 8.0% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.49 earnings per share. Analysts anticipate that Addus HomeCare Corporation will post 6.29 EPS for the current fiscal year.

Addus HomeCare Profile

Addus HomeCare NASDAQ: ADUS is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients' independence and quality of life.

The company's core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.

Want to see what other hedge funds are holding ADUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Addus HomeCare Corporation (NASDAQ:ADUS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source